Advances in the Management of Major Depressive Disorder

home / peers-and-perspective / advances-in-the-management-of-major-depressive-disorder

Dr Andrew Cutler and Dr Greg Mattingly talk about medications with newer mechanisms of action, in particular glutamatergic agents, for the treatment of depression. They also discuss the impact of unresolved depression symptoms, especially anhedonia, on patients’ quality of life and function.

© 2024 MJH Life Sciences

All rights reserved.